The glycolytic enzyme PFKFB3 drives kidney fibrosis through promoting histone lactylation-mediated NF-κB family activation
Kidney International · 2024-08 · 106 (2) · 226-240
DOI: 10.1016/j.kint.2024.04.016 ↗Kurz gefasst
Fachartikel in der Zeitschrift Kidney International, 2024-08. Verfasst von Yating Wang und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China; NHC Key Laboratory of Clinical Nephrology (Sun Yat…. Hauptthemen laut MEDLINE: Phosphofructokinase-2, Fibrosis, Renal Insufficiency, Chronic, Glycolysis. Die Arbeit wurde bisher 220-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Natural Science Foundation of Guangdong Province, National Natural Science Foundation of China, China Postdoctoral Science Foundation.
Abstract (Originalsprache)
Persistently elevated glycolysis in kidney has been demonstrated to promote chronic kidney disease (CKD). However, the underlying mechanism remains largely unclear. Here, we observed that 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 (PFKFB3), a key glycolytic enzyme, was remarkably induced in kidney proximal tubular cells (PTCs) following ischemia-reperfusion injury (IRI) in mice, as well as in multiple etiologies of patients with CKD. PFKFB3 expression was positively correlated with the severity of kidney fibrosis. Moreover, patients with CKD and mice exhibited increased urinary lactate/creatine levels and kidney lactate, respectively. PTC-specific deletion of PFKFB3 significantly reduced kidney lactate levels, mitigated inflammation and fibrosis, and preserved kidney function in the IRI mouse model. Similar protective effects were observed in mice with heterozygous deficiency of PFKFB3 or those treated with a PFKFB3 inhibitor. Mechanistically, lactate derived from PFKFB3-mediated tubular glycolytic reprogramming markedly enhanced histone lactylation, particularly H4K12la, which was enriched at the promoter of NF-κB signaling genes like Ikbkb, Rela, and Relb, activating their transcription and facilitating the inflammatory response. Further, PTC-specific deletion of PFKFB3 inhibited the activation of IKKβ, I κ B α, and p65 in the IRI kidneys. Moreover, increased H4K12la levels were positively correlated with kidney inflammation and fibrosis in patients with CKD. These findings suggest that tubular PFKFB3 may play a dual role in enhancing NF-κB signaling by promoting both H4K12la-mediated gene transcription and its activation. Thus, targeting the PFKFB3-mediated NF-κB signaling pathway in kidney tubular cells could be a novel strategy for CKD therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China; NHC Key Laboratory of Clinical Nephrology (Sun Yat-sen University) and Guangdong Provincial Key Laboratory of Nephrology…
- NHC Key Laboratory of Clinical Nephrology (Sun Yat-sen University) and Guangdong Provincial Key Laboratory of Nephrology, Guangzhou, China; Department of Pathology, the First Affiliated Hospital, Sun Yat-sen University,…
- Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangdong-Hong Kong Joint Laboratory for RNA Medicine, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China; Bas…
Förderung
- Natural Science Foundation of Guangdong Province
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation
Zitieren
APA
Wang, Y., Li, H., Jiang, S., Fu, D., Lu, X., Lu, M., Li, Y., Luo, D., Wu, K., Xu, Y., Li, G., Zhou, Y., Zhou, Y., Chen, W., Liu, Q., & Mao, H. (2024). The glycolytic enzyme PFKFB3 drives kidney fibrosis through promoting histone lactylation-mediated NF-κB family activation. Kidney International, 106(2), 226-240. https://doi.org/10.1016/j.kint.2024.04.016
Vancouver
Wang Y, Li H, Jiang S, Fu D, Lu X, Lu M, et al. The glycolytic enzyme PFKFB3 drives kidney fibrosis through promoting histone lactylation-mediated NF-κB family activation. Kidney International. 2024;106(2):226-240. doi:10.1016/j.kint.2024.04.016
BibTeX
@article{Wang2024,
author = {Wang, Yating and Li, Hongyu and Jiang, Simin and Fu, Dongying and Lu, Xiaohui and Lu, Miaoqing and Li, Yi and Luo, Dan and Wu, Kefei and Xu, Yiping and Li, Guanglan and Zhou, Yi and Zhou, Yiming and Chen, Wei and Liu, Qinghua and Mao, Haiping},
title = {The glycolytic enzyme PFKFB3 drives kidney fibrosis through promoting histone lactylation-mediated NF-κB family activation},
journal = {Kidney International},
year = {2024},
volume = {106},
number = {2},
pages = {226--240},
doi = {10.1016/j.kint.2024.04.016}
}
EUVIMED